These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15841525)

  • 1. DOHMH recommendations for treating at-risk patients.
    AIDS Alert; 2005 Apr; 20(4):39. PubMed ID: 15841525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing gains shown in antiretroviral resistance. Research addresses new recommendations.
    AIDS Alert; 2003 Sep; 18(9):114-7. PubMed ID: 14686306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of a new diagnosis of multidrug-resistant, dual-tropic HIV-1 infection--New York City, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(29):793-6. PubMed ID: 16874293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance patterns analyzed in regional study of HIV patterns. Genotype test is routine for ART-naïve patients.
    AIDS Alert; 2007 May; 22(5):56. PubMed ID: 17577958
    [No Abstract]   [Full Text] [Related]  

  • 7. New resistant strain of HIV worries health officials.
    AIDS Policy Law; 2005 Feb; 20(4):5. PubMed ID: 15779101
    [No Abstract]   [Full Text] [Related]  

  • 8. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.
    Bernstein KT; Liu KL; Begier EM; Koblin B; Karpati A; Murrill C
    Arch Intern Med; 2008 Jul; 168(13):1458-64. PubMed ID: 18625927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.
    Tozzi V; Zaccarelli M; Bonfigli S; Lorenzini P; Liuzzi G; Trotta MP; Forbici F; Gori C; Bertoli A; Bellagamba R; Narciso P; Perno CF; Antinori A;
    Antivir Ther; 2006; 11(5):553-60. PubMed ID: 16964822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of drug-resistant case in New York.
    AIDS Patient Care STDS; 2005 May; 19(5):348. PubMed ID: 15945165
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
    Llibre JM; Domingo P; del Pozo MA; Miralles C; Galindo MJ; Viciana I; Moreno S; Schapiro JM; Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):206-9. PubMed ID: 17999972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive oral fluid rapid HIV tests--New York City, 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):660-5. PubMed ID: 18566566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression.
    Snedecor SJ
    Bull Math Biol; 2005 Nov; 67(6):1315-32. PubMed ID: 16005505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
    Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute HIV infection - New York City, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(46):1296-9. PubMed ID: 19940835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.